Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors

References

• Wagner SJ, Barac S, Garovic VD. Hypertensive pregnancy disorders: current concepts. J Clin Hypertens (Greenwich) 2007;9(7):560–6.
   PubMedGoogle Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25(4):391–403.
   PubMed Web of Science ®Google Scholar
• Maynard SE, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111(5):649–58.
   PubMed Web of Science ®Google Scholar
• Venkatesha S, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12(6):642–9.
   PubMed Web of Science ®Google Scholar
• Levine RJ, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350(7):672–83.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17(1):3–18.
   PubMed Web of Science ®Google Scholar
• Levine RJ, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355(10):992–1005.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, et al. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension 2011;57(1):85–93.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, et al. Severe myocardial impairment and chamber dysfunction in preterm preeclampsia. Hypertens Pregnancy 2012;31(4):454–71.
   PubMed Web of Science ®Google Scholar
• Scantlebury DC, et al. Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart 2015;101(19):1584–90.
   PubMed Web of Science ®Google Scholar
• Shahul S, et al. Circulating antiangiogenic factors and myocardial dysfunction in hypertensive disorders of pregnancy. Hypertension 2016;67(6):1273–80.
   PubMed Web of Science ®Google Scholar
• Erbel R, et al. Echoventriculography – a simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation 1983;67(1):205–15.
   PubMed Web of Science ®Google Scholar
• Bellenger NG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000;21(16):1387–96.
   PubMed Web of Science ®Google Scholar
• Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12(2):426–40.
   PubMed Web of Science ®Google Scholar
• Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation 2014;130(12):1003–8.
   PubMed Web of Science ®Google Scholar
• Lakoumentas JA, et al. The Tei index of myocardial performance: applications in cardiology. Hellenic J Cardiol 2005;46(1):52–8.
   PubMedGoogle Scholar
• Gerede DM, et al. Effects of hemodialysis on tei index: comparison between flow doppler and tissue doppler imaging. Echocardiography 2015;32(10):1520–6.
   PubMed Web of Science ®Google Scholar
• Ozdemir K. et al. Effect of preload and heart rate on the doppler and tissue doppler-derived myocardial performance index. Clin Cardiol 2007;30(7): 342–8.
   PubMed Web of Science ®Google Scholar
• American College of, O., Gynecologists, and P. Task Force on Hypertension in, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122(5):1122–31.
   PubMed Web of Science ®Google Scholar
• Lang RM, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(12):1440–63.
   PubMed Web of Science ®Google Scholar
• Rafik Hamad R, et al. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens 2009;27(11):2257–64.
   PubMed Web of Science ®Google Scholar
• St John Sutton M, Wiegers SE. The Tei index - a role in the diagnosis of heart failure? Eur Heart J 2000;21(22):1822–4.
   PubMed Web of Science ®Google Scholar
• Kapuku GK, et al. Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes. Am Heart J 1993;125(6):1710–6.
   PubMed Web of Science ®Google Scholar
• Yakabe K, et al. Left ventricular mass and global function in essential hypertension after antihypertensive therapy. J Int Med Res 2000;28(1):9–19.
   PubMed Web of Science ®Google Scholar
• Cuocolo A, et al. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990;81(3):978–86.
   PubMed Web of Science ®Google Scholar
• Aeschbacher BC, et al. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 2001;14(2):106–13.
   PubMed Web of Science ®Google Scholar
• Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011;123(24):2856–69.
   PubMed Web of Science ®Google Scholar
• Carr DB, et al. Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. Hypertens Pregnancy 2009;28(1):42–55.
   PubMed Web of Science ®Google Scholar